Crypto
SEC Reviews Nasdaq Bitcoin Options Approval Amid CME Challenge
The US Securities and Exchange Commission (SEC) has announced it will review its approval of Nasdaq-listed bitcoin options after CME Group, a major derivatives exchange, challenged the decision.
CME argued that the SEC's approval of bitcoin options for trading on the Nasdaq was premature and required further evaluation. The SEC had initially cleared the path for the listing in February 2024, but CME's objection has triggered a review process.
The move highlights the ongoing debate surrounding the regulation of cryptocurrency derivatives in the US. While some exchanges have been pushing for greater flexibility in listing these products, others are advocating for stricter oversight to protect investors.